BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting

  March 24, 2025

   · 

  6 min read
• Press Releases

  Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson’s Disease

  March 24, 2025

   · 

  2 min read
• Press Releases

  Sungen Biomedical’s world-first new drug SGC001 monoclonal antibody receives FDA fast track approval

  March 24, 2025

   · 

  1 min read
• Press Releases

  Cliniphai Creates AI-Powered Clinical Trial Localization and Translation Technology of the Future Designed for the Life Sciences Industry

  Named Athena, it combines multiple LLMs with human-in-the-loop control

  March 24, 2025

   · 

  4 min read
• Press Releases

  Singlera Genomics Presented Non-Invasive Testicular Toxicity Detection with Astellas at 2025 SOT Meeting

  March 24, 2025

   · 

  1 min read
• Press Releases

  NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

  March 24, 2025

   · 

  15 min read
• Press Releases

  Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results

  March 24, 2025

   · 

  9 min read
• Press Releases

  Neuron23 to Present Phase 1 Healthy Volunteer Data of NEU-411, a Brain-penetrant LRRK2 Inhibitor, at AD/PD™ 2025

  March 24, 2025

   · 

  3 min read
• Press Releases

  INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025

  March 24, 2025

   · 

  3 min read
• Press Releases

  Sermonix and Regor Announce Strategic Collaboration to Optimize Regor’s Proprietary rCARD Platform for Identification of Novel Targets and Therapeutics

  March 24, 2025

   · 

  5 min read